Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Finance panel recommends no action on medical psilocybin program amid fiscal and staffing concerns
Summary
Division three recommended ITL on HB 1809 (a DHHS-administered medical psilocybin program) after DHHS testified the program would require new positions and startup funding (~$250,000) and the committee expressed concerns about funding, staffing and limited evidence; a minority proposal would keep an advisory board and delay implementation to 2027.
Division three’s members discussed HB 1809, which would authorize a medical psilocybin program administered by the Department of Health and Human Services and governed by an advisory board.
DHHS testimony said the department would need new staff (an administrator and a program manager) and an initial appropriation — the division’s estimate was roughly…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
